Shankar Lal Rampal Dye-Chem Limited reported a substantial improvement in its financial performance for the first quarter of FY26, driven by robust top-line growth and a sharp recovery in bottom-line metrics. The company posted a net profit of ₹918.51 crore for the quarter ended June 30, 2026, marking a 116.83% increase compared to ₹423.61 crore in the corresponding quarter of FY25.

Revenue from operations rose 10.87% year-on-year to ₹13,555.79 crore, up from ₹12,226.70 crore in Q1FY25. This growth trajectory indicates sustained demand across its core segments, contributing to improved operational leverage.

Financial Highlights

In addition to the strong earnings, the company’s Board of Directors approved an interim dividend of ₹1.44 per equity share, up from ₹0.66 per share in the previous year’s same period. This represents a more than doubling of shareholder returns for the quarter.

What the Numbers Show

The divergence between revenue growth (10.87%) and net profit expansion (116.83%) suggests significant operating leverage or favorable non-operating income contributions during the period. While the source does not break down EBITDA explicitly in the summary table, the disproportionate rise in net profit relative to topline indicates either improved cost efficiencies or one-time gains impacting the bottom line. Investors should monitor subsequent filings for clarity on whether this profit surge is sustainable or influenced by exceptional items.

The company has scheduled its Annual General Meeting (AGM) for August 15, 2026, where shareholders will have the opportunity to review these results and vote on related matters. The financial statements were audited in accordance with SEBI regulations and published in both English and vernacular newspapers as required.

Shankar Lal Rampal Dye-Chem has received a legal notice from Police Station Gariahat in West Bengal, marking the beginning of a formal investigation involving the company and its promoters. The notice, dated August 07, 2026, was issued under Section 94 of The Bharatia Nagarik Suraksha Sanhita, 2023 (BNSS), compelling the production of specific documents. This development arises from an ongoing investigation linked to case number 185, which was registered on August 01, 2026.

The disclosure was made to the Bombay Stock Exchange and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that it became aware of the existence of the First Information Report (FIR) only upon receipt of this notice. As of the filing date, Shankar Lal Rampal Dye-Chem had not received a copy of the FIR itself.

The investigation centers on allegations of false representation and wrongful loss. The complainant in the matter is identified as Rajesh Kumar Biyani. The notice names the company, its promoters, and three other individuals as subjects of the inquiry. Management stated that the company categorically denies all allegations made by the complainant.

Investigation Details

The following table outlines the key particulars of the litigation as disclosed by the company:

Financial Implications

The company assessed the immediate financial impact of this development as negligible. In its regulatory filing, Shankar Lal Rampal Dye-Chem stated that the expected financial implications, including any potential compensation or penalties, are "Not applicable." This assessment is based on the nature of the current proceeding, which is strictly a notice for the production of documents rather than a final order or judgment. Similarly, the quantum of claims is listed as not applicable at this stage.

What the Numbers Show

While no financial figures are directly attached to this notice, the timing of the events warrants attention. The gap between the case registration on August 01, 2026, and the receipt of the notice on August 07, 2026, suggests an active investigative phase. The fact that the company received the notice before the FIR copy indicates that law enforcement agencies are prioritizing evidence collection through Section 94 of the BNSS, 2023, which empowers them to call for documents relevant to an investigation. The denial of allegations by management implies that the company intends to contest the findings, potentially leading to prolonged legal proceedings. Investors should monitor subsequent filings for updates on the submission of documents and any further developments in the case.